2024 JP Morgan Healthcare Conference
BRUKER - AN EMERGING LEADER OF THE POST-GENOMIC ERA
Bruker Cellular Analysis:
Beacon® Enables Potential Breakthroughs in Vaccine Development
Dr. Facundo Batista, MIT professor, Ragon Institute:
Focus on B cells and antibody responses in new vaccination strategies
for intractable pathogens, such as malaria, influenza, and HIV
■
■
I
Acquired Beacon in Dec. 2023 to identify mechanisms connecting B
cells with T cells and NK cells in immune response to viral infections
Accelerate breakthroughs in vaccine development, other therapeutics
Beacon® Optofluidic System: The True Single-Cell Functional Multi-omic Platform
Analyze up to 20,000 live individual cells
and cell-cell interactions simultaneously
Serial, multi-parameter functional assays
of single cells and cell-cell interactions
Serial Ag Binding Surface or secreted phenotype
© 2023 Bruker
Beacon
6
11111111111
Dr. Facundo Batista
Associate Director and Scientific Director;
Phillip and Susan Ragon Professor, MIT
"...HIV and malaria are two of the deadliest
pathogens with >1.2 million deaths
annually combined. The Beacon holds
promise in fighting infectious diseases
and deliver help to populations who need
it most."
BRUKER
Link functions with genotype
Selectively export live cells for analysis:
> Proteome & Transcriptome
> TCR / BCR/CAR Sequence
ENSGD0000164687-FABPS
Innovation with Integrity |
EKSGODOC0115523-GNLY
January 8, 2024
1
22View entire presentation